ARIVIN THERAPEUTICS OY (external link)
Novel anti-virulence strategies to treat antimicrobially resistant infections.
Arivin is developing novel strategies that directly target the bacterial properties that cause inflammatory responses in the body: bacterial toxins and biofilm. This novel strategy dramatically reduces inflammatory response to the infection and strengthens the immune system to fight off the bacterial infection. The treatment avoids the development of bacterial resistance, enabling unique commercial opportunities; rapid resistance is a key bottleneck for the development of antibiotic therapies.